New study: can a single shot help fight advanced breast cancer by shutting down ovaries?
Disease control
Not yet recruiting
This early-stage trial is testing a single injection of ZOLADEX 10.8 mg to temporarily stop the ovaries from producing hormones in premenopausal women with a certain type of advanced breast cancer (HR+/HER2-). The goal is to see if the drug can effectively suppress ovarian functi…
Phase: PHASE1 • Sponsor: TerSera Therapeutics LLC • Aim: Disease control
Last updated May 11, 2026 20:37 UTC